Richard R.P. Warner

3.8k total citations
83 papers, 2.7k citations indexed

About

Richard R.P. Warner is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Richard R.P. Warner has authored 83 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 53 papers in Neurology and 47 papers in Oncology. Recurrent topics in Richard R.P. Warner's work include Neuroendocrine Tumor Research Advances (68 papers), Neuroblastoma Research and Treatments (52 papers) and Lung Cancer Research Studies (37 papers). Richard R.P. Warner is often cited by papers focused on Neuroendocrine Tumor Research Advances (68 papers), Neuroblastoma Research and Treatments (52 papers) and Lung Cancer Research Studies (37 papers). Richard R.P. Warner collaborates with scholars based in United States, Germany and United Kingdom. Richard R.P. Warner's co-authors include Thomas M. O’Dorisio, Celia M. Divino, Gregory A. Wiseman, Lowell Anthony, Martyn Caplin, Michelle Kang Kim, Noam Harpaz, A. Louis Southren, Steven H. Itzkowitz and Dennis Carter and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Richard R.P. Warner

82 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard R.P. Warner United States	26	1.9k	1.7k	1.4k	383	277	83	2.7k
Rodney F. Pommier United States	37	3.1k 1.6×	3.3k 1.9×	2.1k 1.6×	769 2.0×	442 1.6×	134	4.7k
Davide Campana Italy	33	2.8k 1.4×	2.8k 1.6×	1.8k 1.3×	487 1.3×	333 1.2×	149	3.5k
Claudio Ricci Italy	31	1.4k 0.7×	1.9k 1.1×	308 0.2×	1.5k 3.8×	1.0k 3.7×	179	3.8k
Anja Rinke Germany	28	4.4k 2.2×	4.0k 2.4×	3.2k 2.4×	222 0.6×	121 0.4×	98	4.6k
David Klaaßen Canada	21	923 0.5×	1.5k 0.9×	557 0.4×	360 0.9×	513 1.9×	37	2.1k
Paola Tomassetti Italy	37	5.2k 2.7×	4.9k 2.9×	3.5k 2.6×	900 2.3×	548 2.0×	117	6.6k
A. J.W. Hilson United Kingdom	26	577 0.3×	561 0.3×	375 0.3×	439 1.1×	611 2.2×	107	2.4k
Yusuf Menda United States	34	1.5k 0.8×	1.6k 0.9×	1.1k 0.8×	690 1.8×	800 2.9×	123	3.8k
Marianne G. Guren Norway	29	864 0.4×	2.4k 1.4×	483 0.4×	1.4k 3.7×	732 2.6×	108	3.3k
Amir Kurtaran Austria	24	765 0.4×	675 0.4×	400 0.3×	302 0.8×	249 0.9×	62	1.7k

Countries citing papers authored by Richard R.P. Warner

Since Specialization

Citations

This map shows the geographic impact of Richard R.P. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard R.P. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard R.P. Warner more than expected).

Fields of papers citing papers by Richard R.P. Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard R.P. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard R.P. Warner. The network helps show where Richard R.P. Warner may publish in the future.

Co-authorship network of co-authors of Richard R.P. Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Richard R.P. Warner. A scholar is included among the top collaborators of Richard R.P. Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard R.P. Warner. Richard R.P. Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dillon, Joseph S., Matthew H. Kulke, Dieter Hörsch, et al.. (2020). Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome. Journal of Gastrointestinal Cancer. 52(1). 212–221. 7 indexed citations

Anthony, Lowell, Matthew H. Kulke, Martyn Caplin, et al.. (2019). Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. The Oncologist. 24(8). e662–e670. 10 indexed citations

Marin, Michael L., et al.. (2019). EndoVascular Occlusion and Tumor Excision (EVOTE): a Hybrid Approach to Small-Bowel Neuroendocrine Tumors with Mesenteric Metastases. Journal of Gastrointestinal Surgery. 23(9). 1911–1916. 3 indexed citations

Dillon, Joseph S., Matthew H. Kulke, Marianne Pavel, et al.. (2018). Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl : Analysis of the Phase 3 TELESTAR Study. Pancreas. 47(3). 337–338. 2 indexed citations

Weickert, Martin O., Gregory Kaltsas, Dieter Hörsch, et al.. (2018). Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period. Pancreas. 47(3). 341–342. 2 indexed citations

Pavel, Marianne, David J. Gross, Marta Benavent, et al.. (2018). Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocrine Related Cancer. 25(3). 309–322. 100 indexed citations

Martin, Jacob A., Richard R.P. Warner, Juan P. Wisnivesky, & Michelle Kang Kim. (2017). Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. European Journal of Cancer. 76. 197–204. 12 indexed citations

Kulke, Matthew H., Dieter Hoersch, Martyn Caplin, et al.. (2016). Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial. Pancreas. 45(3). 478–478. 1 indexed citations

Anthony, Lowell, Dieter Hoersch, Matthew H. Kulke, et al.. (2016). Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome : Patient Exit Interviews. Pancreas. 45(3). 470–470. 1 indexed citations

10.

Jenny, Hillary E., et al.. (2016). Laparoscopic antrectomy: a safe and definitive treatment in managing type 1 gastric carcinoids. The American Journal of Surgery. 211(4). 778–782. 17 indexed citations

11.

Khan, Tahsin M., et al.. (2015). Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors. Pancreas. 45(7). 1032–1035. 8 indexed citations

12.

Nowakowski, F., Edward Kim, A. Fischman, et al.. (2014). Survival following Y90 radioembolization for neuroendocrine tumor liver metastases: A retrospective, single-center analysis.. Journal of Clinical Oncology. 32(15_suppl). e15166–e15166. 3 indexed citations

13.

Amin, Sunil, Richard R.P. Warner, Steven H. Itzkowitz, & Michelle Kang Kim. (2012). The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study. Endocrine Related Cancer. 19(3). 381–387. 16 indexed citations

14.

Anthony, Lowell, Jonathan Strosberg, David S. Klimstra, et al.. (2010). The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs). Pancreas. 39(6). 767–774. 207 indexed citations

15.

Kennedy, Andrew S., Patrick McNeillie, William A. Dezarn, et al.. (2009). Treatment Parameters and Outcome in 680 Treatments of Internal Radiation With Resin 90Y-Microspheres for Unresectable Hepatic Tumors. International Journal of Radiation Oncology*Biology*Physics. 74(5). 1494–1500. 181 indexed citations

16.

Kennedy, Andrew S., William A. Dezarn, Patrick McNeillie, et al.. (2008). Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients. American Journal of Clinical Oncology. 31(3). 271–279. 295 indexed citations

17.

Soliday, Elizabeth, et al.. (2004). Psychosocial Functioning of Carcinoid Cancer Patients: Test of a Stress and Coping Mediated Model1. Journal of Applied Biobehavioral Research. 9(3). 156–171. 2 indexed citations

18.

Warner, Richard R.P. & Thomas M. O’Dorisio. (2002). Radiolabeled peptides in diagnosis and tumor imaging: Clinical overview. Seminars in Nuclear Medicine. 32(2). 79–83. 52 indexed citations

19.

Warner, Richard R.P. & W. C. Luth. (1973). Two-phase data for the join monticellite (CaMgSiO4)-forsterite (Mg2SiO4): Experimental results and numerical analysis. American Mineralogist. 58. 998–1008. 49 indexed citations

20.

Simon, Norman, et al.. (1968). INTRA-ARTERIAL IRRADIATION OF CARCINOID TUMORS OF THE LIVER. American Journal of Roentgenology. 102(3). 552–561. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact